<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35510476</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-1654</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Reviews in medical virology</Title><ISOAbbreviation>Rev Med Virol</ISOAbbreviation></Journal><ArticleTitle>Insight into the Enterovirus A71: A review.</ArticleTitle><Pagination><StartPage>e2361</StartPage><MedlinePgn>e2361</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/rmv.2361</ELocationID><Abstract><AbstractText>Enterovirus A71 is a major causative pathogen of hand, foot and mouth disease. It has become a global public health threat, and is especially important for infants and young children in the Asian-Pacific countries. The enterovirus A71 is a non-enveloped virus of the Picornaviridae family having a single-stranded positive-sense RNA genome of about 7.4 kb which encodes the structural and nonstructural proteins. Currently there are no US FDA-approved vaccines or antiviral therapy available against enterovirus A71 infection. Although enterovirus A71 vaccines have been licenced in China, clinically approved vaccines for widespread vaccination programs are lacking. Substantial progress has recently been achieved on understanding the structure and function of enterovirus A71 proteins together with information on the viral genetic diversity and geographic distribution. The present review is intended to provide an overview on our current understanding of the molecular biology and epidemiology of enterovirus A71 which will aid the development of vaccines, therapeutics and other control strategies so as to bolster the preparedness for future enterovirus A71 outbreaks.</AbstractText><CopyrightInformation>© 2022 John Wiley &amp;amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kinobe</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Mathematics and Natural Sciences, Bogor Agricultural University, Bogor, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiyatno</LastName><ForeName>Ageng</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Eijkman Institute for Molecular Biology, Jakarta, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Artika</LastName><ForeName>I Made</ForeName><Initials>IM</Initials><Identifier Source="ORCID">0000-0003-4293-3389</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Mathematics and Natural Sciences, Bogor Agricultural University, Bogor, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Eijkman Institute for Molecular Biology, Jakarta, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Safari</LastName><ForeName>Dodi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Eijkman Institute for Molecular Biology, Jakarta, Indonesia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Rev Med Virol</MedlineTA><NlmUniqueID>9112448</NlmUniqueID><ISSNLinking>1052-9276</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="Y">Viral Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enterovirus A71</Keyword><Keyword MajorTopicYN="N">Picornaviridae</Keyword><Keyword MajorTopicYN="N">antiviral agent</Keyword><Keyword MajorTopicYN="N">biochemistry</Keyword><Keyword MajorTopicYN="N">foot and mouth disease</Keyword><Keyword MajorTopicYN="N">genetics</Keyword><Keyword MajorTopicYN="N">hand</Keyword><Keyword MajorTopicYN="N">microbiology</Keyword><Keyword MajorTopicYN="N">molecular biology</Keyword><Keyword MajorTopicYN="N">molecular epidemiology</Keyword><Keyword MajorTopicYN="N">vaccine</Keyword><Keyword MajorTopicYN="N">virology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>5</Day><Hour>4</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35510476</ArticleId><ArticleId IdType="doi">10.1002/rmv.2361</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>WHO. Enterovirus 71; 2022. Accessed April 6, 2022. https://www.who.int/teams/health-product-and-policy-standards/standards-and-specifications/vaccine-standardization/enterovirus-71</Citation></Reference><Reference><Citation>Lee KY. Enterovirus 71 infection and neurological complications. Korean J Pediatr. 2016;59:395-401. https://doi.org/10.3345/kjp.2016.59.10.395. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099286/pdf/kjped-59-395.pdf</Citation></Reference><Reference><Citation>Chu ST, Kobayashi K, Bi X, et al. Newly emerged Enterovirus-A71 C4 sublineage may be more virulent than B5 in the 2015-2016 handfoot-and-mouth disease outbreak in northern Vietnam. Sci Rep. 2020;10:1-11. https://doi.org/10.1038/s41598-019-56703-5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6957505/</Citation></Reference><Reference><Citation>Tee KK, Lam TT-Y, Chan YF, et al. Evolutionary genetics of human Enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene. J Virol. 2010;84:339-350. https://doi.org/10.1128/JVI.01019-09. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2838098/</Citation></Reference><Reference><Citation>Yip CCY, Lau SKP, Woo PCY, Yuen K-Y. Human enterovirus 71 epidemics: what's next? Emerg Health Threats J. 2013;6:1-17. https://doi.org/10.3402/ehtj.v6i0.19780. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772321/</Citation></Reference><Reference><Citation>Baggen J, Thibaut HJ, Strating JRPM, Van Kuppeveld FJM. The life cycle of non-polio enteroviruses and how to target it. Nat Rev Microbiol. 2018;16:368-381. https://doi.org/10.1038/s41579-018-0005-4. https://www.nature.com/articles/s41579-018-0005-4</Citation></Reference><Reference><Citation>Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis. 1974;129:304-309. https://doi.org/10.1093/infdis/129.3.304. https://pubmed.ncbi.nlm.nih.gov/4361245/</Citation></Reference><Reference><Citation>Chang P-C, Chen S-C, Chen K-T. The current status of the disease caused by Enterovirus 71 infections: epidemiology, pathogenesis, molecular epidemiology, and vaccine development. Int J Environ Res Public Health. 2016;13:29-34. https://doi.org/10.3390/ijerph13090890. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036723/</Citation></Reference><Reference><Citation>Wiyatno A, Hartoyo E, Jaya AU, et al. Detection and genetic characterization of human enterovirus A71 from hand, foot and mouth disease cases in Banjarmasin, Indonesia. Southeast Asian J Trop Med Public Health. 2018;49:820-825. https://www.tm.mahidol.ac.th/seameo/2018-49-5/10-7448-11-820.pdf</Citation></Reference><Reference><Citation>Apostol LN, Shimizu H, Suzuki A, et al. Molecular characterization of enterovirus A71 in children with acute flaccid paralysis in the Philippines. BMC Infect Dis. 2019;19:1-8. https://doi.org/10.1186/s12879-019-3955-x. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498601/</Citation></Reference><Reference><Citation>Lin J-Y, Shih S-R. Cell and tissue tropism of enterovirus 71 and other enteroviruses infections. J Biomed Sci. 2014;21:1-6. https://doi.org/10.1186/1423-0127-21-18. http://www.jbiomedsci.com/content/21/1/18</Citation></Reference><Reference><Citation>Mandary M, Poh CL. Changes in the EV-A71 genome through recombination and spontaneous mutations: impact on virulence. Viruses. 2018;10:1-21. https://doi.org/10.3390/v10060320. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024729/</Citation></Reference><Reference><Citation>Huang S-W, Cheng D, Wang J-R. Enterovirus A71: virulence, antigenicity, and genetic evolution over the years. J Biomed Sci. 2019;26:1-9. https://doi.org/10.1186/s12929-019-0574-1. https://jbiomedsci.biomedcentral.com/articles/10.1186/s12929-019-0574-1</Citation></Reference><Reference><Citation>Chang C-K, Wu S-R, Chen Y-C, et al. Mutations in VP1 and 5′-UTR affect enterovirus 71 virulence. Sci Rep. 2018;8:1-11. https://doi.org/10.1038/s41598-018-25091-7. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923339/</Citation></Reference><Reference><Citation>Woodman A, Lee K-M, Janissen R, et al. Predicting intraserotypic recombination in enterovirus 71. J Virol. 2019;93:1-15. https://doi.org/10.1128/JVI.02057-18. https://jvi.asm.org/content/93/4/e02057-18</Citation></Reference><Reference><Citation>Xu L, Qi M, Ma C, et al. Natural intertypic and intratypic recombinants of enterovirus 71 from mainland China during 2009-2018: a complete genome analysis. Virus Genes. 2021;57:172-180. https://doi.org/10.1007/s11262-021-01830-3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877514/</Citation></Reference><Reference><Citation>Kobayashi K, Koike S. Cellular receptors for enterovirus A71. J Biomed Sci. 2020;27:1-12. https://doi.org/10.1186/s12929-020-0615-9. https://jbiomedsci.biomedcentral.com/articles/10.1186/s12929-020-0615-9</Citation></Reference><Reference><Citation>Cox JA, Hiscox JA, Solomon T, Ooi M-H, Ng LFP. Immunopathogenesis and virus-host interactions of enterovirus 71 in patients with hand, foot and mouth disease. Front Microbiol. 2017;8:1-14. https://doi.org/10.3389/fmicb.2017.02249. https://www.frontiersin.org/articles/10.3389/fmicb.2017.02249/full</Citation></Reference><Reference><Citation>Owino CO, Chu JH. Recent advances on the role of host factors during non-poliovirus enteroviral infections. J Biomed Sci. 2019;26:1-17. https://doi.org/10.1186/s12929-019-0540-y</Citation></Reference><Reference><Citation>Fu Y, Zhang L, Zhang F, et al. Exosome-mediated miR-146a transfer suppresses type I interferon response and facilitates EV-A71 infection. PLoS Pathog. 2017;13:1-31. https://doi.org/10.1371/journal.ppat.1006611</Citation></Reference><Reference><Citation>Shih SR, Stollar V, Li M-L. Host factors in enterovirus 71 replication. J Virol. 2011;85:9658-9666. https://doi.org/10.1128/JVI.05063-11. https://jvi.asm.org/content/85/19/9658</Citation></Reference><Reference><Citation>Van der Linden L, Wolthers KC, Van Kuppeveld FJM. Replication and inhibitors of enteroviruses and parechoviruses. Viruses. 2015;7:4529-4562. https://doi.org/10.3390/v7082832. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576193/</Citation></Reference><Reference><Citation>Saxena VK, Sane S, Nadkarni S, Sharma DK, Deshpande JM. Genetic diversity of enterovirus A71, India. Emerg Infect Dis. 2015;21:123-126. https://doi.org/10.3201/eid2101.140743. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285237/</Citation></Reference><Reference><Citation>Bessaud M, Razafindratsimandresy R, Nougairède A, et al. Molecular comparison and evolutionary analyses of VP1 nucleotide sequences of new African human enterovirus 71 isolates reveal a wide genetic diversity. PLoS One. 2014;9:1-9. https://doi.org/10.1371/journal.pone.0090624. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944068/</Citation></Reference><Reference><Citation>Fernandez-Garcia MD, Volle R, Joffret M-L, et al. Genetic characterization of enterovirus A71 circulating in Africa. Emerg Infect Dis. 2018;24:754-757. https://doi.org/10.3201/eid2404.171783. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875259/</Citation></Reference><Reference><Citation>Volle R, Razafindratsimandresy R, Joffret M-L, et al. High permissiveness for genetic exchanges between enteroviruses of species A, including enterovirus 71, favors evolution through intertypic recombination in Madagascar. J Virol. 2019;93:1-17. https://doi.org/10.1128/JVI.01667-18. https://jvi.asm.org/content/93/6/e01667-18</Citation></Reference><Reference><Citation>Plevka P, Perera R, Cardosa J, Kuhn RJ, Rossmann MG. Crystal structure of human enterovirus 71. Science. 2012;336:1-3. https://doi.org/10.1126/science.1218713. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448362/</Citation></Reference><Reference><Citation>Plevka P, Perera R, Yap ML, Cardosa J, Kuhn R, Rossmann MG. Structure of human enterovirus 71 in complex with a capsid-binding inhibitor. Proc Ntl Acad Sci. 2013;110:5463-5467. https://doi.org/10.1073/pnas.1222379110</Citation></Reference><Reference><Citation>Kiener TK, Jia Q, Lim XF, et al. Characterization and specificity of the linear epitope of the enterovirus 71 VP2 protein. Virol J. 2012;9:1-11. https://doi.org/10.1186/1743-422x-9-55. https://virologyj.biomedcentral.com/articles/10.1186/1743-422X-9-55</Citation></Reference><Reference><Citation>Noisumdaeng P, Sangsiriwut K, Prasertsopon J, et al. Complete genome analysis demonstrates multiple introductions of enterovirus 71 and coxsackievirus A16 recombinant strains into Thailand during the past decade. Emerg Microb Infect. 2018;7:1-12. https://doi.org/10.1038/s41426-018-0215-x</Citation></Reference><Reference><Citation>Sun Y, Wang Y, Shan C, et al. Enterovirus 71 VPg uridylation uses a two-molecular mechanism of 3D polymerase. J Virol. 2012;86:13662-13671. https://doi.org/10.1128/JVI.01712-12. https://jvi.asm.org/content/86/24/13662</Citation></Reference><Reference><Citation>Chen C, Wang Y, Shan C, et al. Crystal structure of enterovirus 71 RNA-dependent RNA polymerase complexed with its protein primer VPg: implication for a trans mechanism of VPg uridylylation. J Virol. 2013;87:5755-5768. https://doi.org/10.1128/JVI.02733-12. https://pubmed.ncbi.nlm.nih.gov/23487447/</Citation></Reference><Reference><Citation>Su Y-S, Tsai A-H, Ho Y-F, Huang S-Y, Liu Y-C, Hwang L-H. Stimulation of the internal ribosome entry site (IRES)-dependent translation of enterovirus 71 by DDX3X RNA helicase and viral 2A and 3C proteases. Front Microbiol. 2018;9:1-17. https://doi.org/10.3389/fmicb.2018.01324. https://pubmed.ncbi.nlm.nih.gov/29971060/</Citation></Reference><Reference><Citation>Davila-Calderon J, Patwardhan NN, Chiu L-Y, et al. IRES-targeting small molecule inhibits enterovirus 71 replication via allosteric stabilization of a ternary complex. Nat Commun. 2020;11:1-13. https://doi.org/10.1038/s41467-020-18594-3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508794/</Citation></Reference><Reference><Citation>Kok CC, Phuektes P, Bek E, McMinn PC. Modification of the untranslated regions of human enterovirus 71 impairs growth in a cell-specific manner. J Virol. 2012;86:542-552. https://doi.org/10.1128/JVI.00069-11. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255918/</Citation></Reference><Reference><Citation>Wang H, Li Y. Recent progress on functional genomics research of enterovirus 71. Virol Sin. 2019;34:9-21. https://doi.org/10.1007/s12250-018-0071-9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420560/</Citation></Reference><Reference><Citation>Yuan J, Shen L, Wu J, et al. Enterovirus A71 proteins: structure and function. Front Microbiol. 2018;9:1-12. https://doi.org/10.3389/fmicb.2018.00286. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826392/</Citation></Reference><Reference><Citation>Wen B-P, Dai H-J, Yang Y-H, Zhuang Y, Sheng R. MicroRNA-23b inhibits enterovirus 71 replication through downregulation of EV-A71 VPl protein. Intervirology. 2013;56:195-200. https://doi.org/10.1159/000348504. https://pubmed.ncbi.nlm.nih.gov/23594713/</Citation></Reference><Reference><Citation>Liu Z-W, Zhuang Z-C, Chen R, et al. Enterovirus 71 VP1 protein regulates viral replication in SH-SY5Y cells via the mTOR autophagy signaling pathway. Viruses. 2020;12:1-14. https://doi.org/10.3390/v12010011. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019657/</Citation></Reference><Reference><Citation>Jia Q, Ng Q, Chin W, et al. Effective in vivo therapeutic IgG antibody against VP3 of enterovirus 71 with receptor-competing activity. Sci Rep. 2017;7:1-14. https://doi.org/10.1038/srep46402. https://pubmed.ncbi.nlm.nih.gov/28422137/</Citation></Reference><Reference><Citation>Huang K-Y, Chen M-F, Huang Y-C, et al. Epitope-associated and specificity-focused features of EV-A71-neutralizing antibody repertoires from plasmablasts of infected children. Nat Commun. 2017;8:1-14. https://doi.org/10.1038/s41467-017-00736-9. https://pubmed.ncbi.nlm.nih.gov/28970483/</Citation></Reference><Reference><Citation>Cao J, Qu M, Liu H, et al. Myristoylation of EV-A71 VP4 is essential for infectivity and interaction with membrane structure. Vir Sin. 2020;35:599-613. https://doi.org/10.1007/s12250-020-00226-1. https://link.springer.com/article/10.1007/s12250-020-00226-1</Citation></Reference><Reference><Citation>Cai Q, Yameen M, Liu W, et al. Conformational plasticity of the 2A proteinase from enterovirus 71. J Virol. 2013;87:7348-7356. https://doi.org/10.1128/JVI.03541-12. https://jvi.asm.org/content/87/13/7348</Citation></Reference><Reference><Citation>Mu Z, Wang B, Zhang X, et al. Crystal structure of 2A proteinase from hand, foot and mouth disease virus. J Mol Biol. 2013;425:4530-4543. https://doi.org/10.1016/j.jmb.2013.08.016. https://www.sciencedirect.com/science/article/abs/pii/S0022283613005366</Citation></Reference><Reference><Citation>Wang B, Xi X, Lei X, et al. Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses. PLoS Pathog. 2013;9:1-18. https://doi.org/10.1371/journal.ppat.1003231. https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1003231</Citation></Reference><Reference><Citation>Li C, Qiao Q, Hao S-B, et al. Nonstructural protein 2A modulates replication and virulence of enterovirus 71. Virus Res. 2018;244:262-269. https://doi.org/10.1016/j.virusres.2017.11.023. https://pubmed.ncbi.nlm.nih.gov/29175108/</Citation></Reference><Reference><Citation>Xie S, Wang K, Yu W, et al. DIDS blocks a chloride-dependent current that is mediated by the 2B protein of enterovirus 71. Cell Res. 2011;21:1271-1275. https://doi.org/10.1038/cr.2011.112. https://www.nature.com/articles/cr2011112</Citation></Reference><Reference><Citation>Du H, Yin P, Yang X, Zhang L, Jin Q, Zhu G. Enterovirus 71 2C protein inhibits NF-κB activation by binding to RelA(p65). Sci Rep. 2015;5:1-8. https://doi.org/10.1038/srep14302. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585786/</Citation></Reference><Reference><Citation>Guan H, Tian J, Qin B, et al. Crystal structure of 2C helicase from enterovirus 71. Sci Adv. 2017;3:1-9. https://doi.org/10.1126/sciadv.1602573. https://advances.sciencemag.org/content/3/4/e1602573</Citation></Reference><Reference><Citation>Xiao X, Lei X, Zhang Z, et al. Enterovirus 3A facilitates viral replication by promoting phosphatidylinositol 4-kinase IIIβ-ACBD3 interaction. J Virol. 2017;91:1-14. https://doi.org/10.1128/JVI.00791-17. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599760/</Citation></Reference><Reference><Citation>Yang W, Li D, Ru Y, et al. Foot-and-mouth disease virus 3A protein causes upregulation of autophagy-related protein LRRC25 to inhibit the G3BP1-mediated RIG-like helicase-signaling pathway. J Virol. 2020;94:1-14. https://doi.org/10.1128/JVI.02086-19. https://jvi.asm.org/content/94/8/e02086-19</Citation></Reference><Reference><Citation>Cui S, Wang J, Fan T, et al. Crystal structure of human enterovirus 71 3C protease. J Mol Biol. 2011;408:449-461. https://doi.org/10.1016/j.jmb.2011.03.007. https://pubmed.ncbi.nlm.nih.gov/21396941/</Citation></Reference><Reference><Citation>Lei X, Han N, Xiao X, Jin Q, He B, Wang J. Enterovirus 71 3C inhibits cytokine expression through cleavage of the TAK1/TAB1/TAB2/TAB3 complex. J Virol. 2014;88:9830-9841. https://doi.org/10.1128/JVI.01425-14. https://jvi.asm.org/content/88/17/9830</Citation></Reference><Reference><Citation>Wen W, Qi Z, Wang J. The function and mechanism of enterovirus 71 (EV-A71) 3C protease. Curr Microbiol. 2020;77:1968-1975. https://doi.org/10.1007/s00284-020-02082-4. https://pubmed.ncbi.nlm.nih.gov/32556480/</Citation></Reference><Reference><Citation>Wang LC, Chen S-O, Chang S-P, et al. Enterovirus 71 proteins 2A and 3D antagonize the antiviral activity of gamma interferon via signaling attenuation. J Virol. 2015;89:7028-7037. https://doi.org/10.1128/JVI.00205-15. https://pubmed.ncbi.nlm.nih.gov/25926657/</Citation></Reference><Reference><Citation>Yu J, Zhang L, Ren P, et al. Enterovirus 71 mediates cell cycle arrest in S phase through non-structural protein 3D. Cell Cycle. 2015;14:425-436. https://doi.org/10.4161/15384101.2014.980631. https://pubmed.ncbi.nlm.nih.gov/25659038/</Citation></Reference><Reference><Citation>Wang W, Xiao F, Wan P, et al. EV-A71 3D protein binds with NLRP3 and enhances the assembly of inflammasome complex. PLoS Pathog. 2017;13:1-30. https://doi.org/10.1371/journal.ppat.1006123. https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1006123</Citation></Reference><Reference><Citation>Cong H, Du N, Yang Y, Song L, Zhang W, Tien P. Enterovirus 71 2B induces cell apoptosis by directly inducing the conformational activation of the proapoptotic protein Bax. J Virol. 2016;90:9862-9877. https://doi.org/10.1128/JVI.01499-16. https://pubmed.ncbi.nlm.nih.gov/27558414/</Citation></Reference><Reference><Citation>Supasorn O, Tongtawe P, Srimanote P, Rattanakomol P, Thanongsaksrikul J. A nonstructural 2B protein of enterovirus A71 increases cytosolic Ca2+ and induces apoptosis in human neuroblastoma SH-SY5Y cells. J. Neurovirology. 2020;26:201-213. https://doi.org/10.1007/s13365-019-00824-0. https://link.springer.com/article/10.1007/s13365-019-00824-0</Citation></Reference><Reference><Citation>Li Q, Zheng Z, Liu Y, et al. 2C proteins of enteroviruses suppress IKKβ phosphorylation by recruiting protein phosphatase. J Virol. 2016;90:5141-5151. https://doi.org/10.1128/JVI.03021-15. https://pubmed.ncbi.nlm.nih.gov/26962213/</Citation></Reference><Reference><Citation>Lei X, Xiao X, Zhang Z, et al. The Golgi protein ACBD3 facilitates Enterovirus 71 replication by interacting with 3A. Sci Rep. 2017;7:1-12. https://doi.org/10.1038/srep44592. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356004/</Citation></Reference><Reference><Citation>Lyoo H, van der Schaar HM, Dorobantu CM, Rabouw HH, Strating JRPM, van Kuppeveld FJM. ACBD3 is an essential pan-enterovirus host factor that mediates the interaction between viral 3A protein and cellular protein PI4KB. mBio. 2019;10:1-15. https://doi.org/10.1128/mBio.02742-18. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372799/</Citation></Reference><Reference><Citation>Xie L, Lu B, Zheng Z, et al. The 3C protease of enterovirus A71 counteracts the activity of host zinc-finger antiviral protein (ZAP). J Gen Virol. 2018;99:73-85. https://doi.org/10.1099/jgv.0.000982. https://www.microbiologyresearch.org/content/journal/jgv/10.1099/jgv.0.000982#tab2</Citation></Reference><Reference><Citation>Yao C, Xi C, Hu K, et al. Inhibition of enterovirus 71 replication and viral 3C protease by quercetin. Virol J. 2018;15:1-13. https://doi.org/10.1186/s12985-018-1023-6</Citation></Reference><Reference><Citation>Jiang H, Weng L, Zhang N, et al. Biochemical characterization of enterovirus 71 3D RNA polymerase. Biochim Biophys Acta. 2011;1809:211-219. https://doi.org/10.1016/j.bbagrm.2011.01.001. https://www.sciencedirect.com/science/article/abs/pii/S1874939911000149</Citation></Reference><Reference><Citation>Li Y, Yu Y, Qi X, Yan H. Monoclonal antibody against EV-A71 3Dpol inhibits the polymerase activity of RdRp and virus replication. BMC Immunol. 2019;20:1-8. https://doi.org/10.1186/s12865-019-0288-x. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343263/</Citation></Reference><Reference><Citation>Yang S-L, Chou Y-T, Wu C-N, Ho M-S. Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity. J Virol. 2011;85:11809-11820. https://doi.org/10.1128/JVI.00297-11. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3209289/</Citation></Reference><Reference><Citation>Nishimura Y, Lee H, Hafenstein S, et al. Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interaction. PLoS Pathog. 2013;9:1-12. https://doi.org/10.1371/journal.ppat.1003511. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723564/</Citation></Reference><Reference><Citation>Yamayoshi S, Fujii K, Koike S. Receptors for enterovirus 71. Emerg Microb Infect. 2014;3:1-7. https://doi.org/10.1038/emi.2014.49. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126179/</Citation></Reference><Reference><Citation>Hussain KM, Leong KLJ, Ng MM-L, Chu JJH. The essential role of clathrin-mediated endocytosis in the infectious entry of human enterovirus 71. J Biol Chem. 2011;286:309-321. https://doi.org/10.1074/jbc.M110.168468. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012988/</Citation></Reference><Reference><Citation>Chen P, Song Z, Qi Y, et al. Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2. J Biol Chem. 2012;287:6406-6420. https://doi.org/10.1074/jbc.M111.301622. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307280/</Citation></Reference><Reference><Citation>Ross CJ, Atilgan AR, Bishop ÖT, Atilgan C. Unraveling the motions behind enterovirus 71 uncoating. Biophys J. 2018;114:822-838. https://doi.org/10.1016/j.bpj.2017.12.021. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984953/</Citation></Reference><Reference><Citation>Lyu K, Ding J, Han J-F, et al. Human enterovirus 71 uncoating captured at atomic resolution. J Virol. 2014;88:3114-3126. https://doi.org/10.1128/JVI.03029-13. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3957924/</Citation></Reference><Reference><Citation>Shingler KL, Yoder JL, Carnegie MS, et al. The enterovirus 71 A-particle forms a gateway to allow genome release: a cryoEM study of picornavirus uncoating. PLoS Pathog. 2013;9:1-10. https://doi.org/10.1371/journal.ppat.1003240. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605244/</Citation></Reference><Reference><Citation>Melia CE, Peddie CJ, de Jong AWM, et al. Origins of enterovirus replication organelles established by whole-cell electron microscopy. mBio. 2019;10:1-12. https://doi.org/10.1128/mBio.00951-19</Citation></Reference><Reference><Citation>Li X, Wang M, Cheng A, et al. Enterovirus replication organelles and inhibitors of their formation. Front Microbiol. 2020;11:1-14. https://doi.org/10.3389/fmicb.2020.01817. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468505/</Citation></Reference><Reference><Citation>Wang J, Wu Z, Jin Q. COPI is required for enterovirus 71 replication. PLoS One. 2012;7:1-10. https://doi.org/10.1371/journal.pone.0038035. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360637/</Citation></Reference><Reference><Citation>Li X, Wang M, Cheng A, et al. Enterovirus replication organelles and inhibitors of their formation. Front Microbiol. 2020;11:1-14. https://doi.org/10.3389/fmicb.2020.01817. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468505/</Citation></Reference><Reference><Citation>Pathinayake PS, Hsu AC-Y, Wark PAB. Innate immunity and immune evasion by enterovirus 71. Viruses. 2015;7:6613-6630. https://doi.org/10.3390/v7122961. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690884/</Citation></Reference><Reference><Citation>Chen K-R, Ling P. Interplays between Enterovirus A71 and the innate immune system. J Biomed Sci. 2019;26:1-11. https://doi.org/10.1186/s12929-019-0596-8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886175/</Citation></Reference><Reference><Citation>Gantt S, Yao L, Kollmann TR, Casper C, Zhang J, Self SG. Implications of age-dependent immune responses to enterovirus 71 infection for disease pathogenesis and vaccine design. J Pediatric Infect Dis Soc. 2013;2:162-170. https://doi.org/10.1093/jpids/pit017. https://academic.oup.com/jpids/article/2/2/162/915894</Citation></Reference><Reference><Citation>Zhao T, Zhang Z, Zhang Y, et al. Dynamic interaction of enterovirus 71 and dendritic cells in infected neonatal rhesus macaques. Front Cell Infect Microbiol. 2017;7:1-13. https://doi.org/10.3389/fcimb.2017.00171. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423916/</Citation></Reference><Reference><Citation>Cheng H, Zeng J, Li H, Li Y, Wang W. Neuroimaging of HFMD infected by EV71. Radiol Infect Dis. 2015;1:103-108. https://doi.org/10.1016/j.jrid.2015.02.006</Citation></Reference><Reference><Citation>Shang W, Qian S, Fang L, Han Y, Zheng C. Association study of inflammatory cytokine and chemokine expression in hand foot and mouth disease. Oncotarget. 2017;8:79425-79432. https://doi.org/10.18632/oncotarget.18341. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668054/</Citation></Reference><Reference><Citation>Jin Y, Zhang R, Wu W, Duan G. Antiviral and inflammatory cellular signaling associated with enterovirus 71 infection. Viruses. 2018;10:1-14. https://doi.org/10.3390/v10040155. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923449/</Citation></Reference><Reference><Citation>Kuo R-L, Chen C-J, Wang RYL, et al. Role of enteroviral RNA-dependent RNA polymerase in regulation of MDA5-mediated beta interferon activation. J Virol. 2019;93:1-13. https://doi.org/10.1128/JVI.00132-19. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498057/</Citation></Reference><Reference><Citation>Melnick JL. Enterovirus type 71 infections: a varied clinical pattern sometimes mimicking paralytic poliomyelitis. Rev Infect Dis. 1984;6:387-390. https://doi.org/10.1093/clinids/6.supplement_2.s387. https://pubmed.ncbi.nlm.nih.gov/6330839/</Citation></Reference><Reference><Citation>Deibel R, Gross LL, Collins DN. Isolation of a new enterovirus. Proc Soc Exp Biol Med. 1975;148:203-207. https://doi.org/10.3181/00379727-148-38506</Citation></Reference><Reference><Citation>McMinn P. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev. 2002;26:91-107. https://doi.org/10.1111/j.1574-6976.2002.tb00601.x. https://pubmed.ncbi.nlm.nih.gov/12007645/</Citation></Reference><Reference><Citation>Takimoto S, Waldmanz EA, Moreira RC, et al. Enterovirus 71 infection and acute neurological disease among children in Brazil (1988-1990). Trans R Soc Trop Med Hyg. 1998;92:25-28. https://doi.org/10.1016/s0035-9203(98)90939-7. https://pubmed.ncbi.nlm.nih.gov/9692141/</Citation></Reference><Reference><Citation>Castro CMO, Cruz ACR, da Silva EE, Gomes MDLC. Molecular and seroepidemiologic studies of Enterovirus 71 infection in the state of Para, Brazil. Rev Inst Med Trop Sao Paulo. 2005;47:65-71. https://doi.org/10.1590/s0036-46652005000200002. https://pubmed.ncbi.nlm.nih.gov/15880216/</Citation></Reference><Reference><Citation>Shindarov LM, Chumakov MP, Voroshilova MK, et al. Epidemiological, clinical, and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71. J Hyg Epidemiol Microbiol Immunol. 1979;23:284-295. https://pubmed.ncbi.nlm.nih.gov/231067/</Citation></Reference><Reference><Citation>Chumakov M, Voroshilova M, Shindarov L, et al. Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch Virol. 1979;60:329-340. https://doi.org/10.1007/BF01317504. https://pubmed.ncbi.nlm.nih.gov/228639/</Citation></Reference><Reference><Citation>Melnick JL, Schmidt NJ, Mirkovic RR, Chumakov MP, Lavrova IK, Voroshilova MK. Identification of Bulgarian strain 258 of enterovirus 71. Intervirology. 1980;12:297-302. https://doi.org/10.1159/000149088. https://pubmed.ncbi.nlm.nih.gov/6244233/</Citation></Reference><Reference><Citation>Nagy G, Takátsy S, Kukán E, Mihály I, Dömök I. Virological diagnosis of enterovirus type 71 infections: experiences gained during an epidemic of acute CNS diseases in Hungary in 1978. Arch Virol. 1982;71:217-227. https://doi.org/10.1007/BF01314873. https://pubmed.ncbi.nlm.nih.gov/6285858/</Citation></Reference><Reference><Citation>Van der Sanden S, Koopmans M, Uslu G, van der Avoort H. Epidemiology of enterovirus 71 in The Netherlands, 1963 to 2008. J Clin Microbiol. 2009;47:2826-2833. https://doi.org/10.1128/JCM.00507-09. https://jcm.asm.org/content/47/9/2826</Citation></Reference><Reference><Citation>Bible JM, Iturriza-Gomara M, Megson B, et al. Molecular epidemiology of human enterovirus 71 in the United Kingdom from 1998 to 2006. J Clin Microbiol. 2008;46:3192-3200. https://doi.org/10.1128/JCM.00628-08. https://jcm.asm.org/content/46/10/3192</Citation></Reference><Reference><Citation>Richter J, Tryfonos C, Christodoulou C. Molecular epidemiology of enteroviruses in Cyprus 2008-2017. PLoS One. 2019;14:1-18. https://doi.org/10.1371/journal.pone.0220938. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687182/</Citation></Reference><Reference><Citation>Badran SA, Midgley S, Andersen P, Böttiger B. Clinical and virological features of enterovirus 71 infections in Denmark, 2005 to 2008. Scand J Infect Dis. 2011;43:642-648. https://doi.org/10.3109/00365548.2011.577094. https://pubmed.ncbi.nlm.nih.gov/21526904/</Citation></Reference><Reference><Citation>Fischer TK, Nielsen AY, Sydenham TV, Andersen PH, Andersen B, Midgley SE. Emergence of enterovirus 71 C4a in Denmark, 2009 to 2013. Euro Surveill. 2014;19:1-6. https://doi.org/10.2807/1560-7917.es2014.19.38.20911. https://www.eurosurveillance.org/content/10.2807/1560-7917.ES2014.19.38.20911</Citation></Reference><Reference><Citation>Vallet S, Legrand-Quillien M-C, Dailland T, et al. Fatal case of enterovirus 71 infection, France, 2007. Emerg Infect Dis. 2009;15:1837-1840. https://doi.org/10.3201/eid1511.090493. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857235/</Citation></Reference><Reference><Citation>Schuffenecker I, Henquell C, Mirand A, et al. New introductions of enterovirus 71 subgenogroup C4 strains, France, 2012. Emerg Infect Dis. 2014;20:1343-1346. https://doi.org/10.3201/eid2008.131858. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111202/</Citation></Reference><Reference><Citation>Mirand A, Molet L, Hassel C, et al. Enterovirus A71 subgenotype B5, France, 2013. Emerg Infect Dis. 2015;21:707-709. https://doi.org/10.3201/eid2104.141093. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378463/</Citation></Reference><Reference><Citation>Ngangas ST, Lukashev A, Jugie G, et al. Multirecombinant enterovirus A71 subgenogroup C1 isolates associated with neurologic disease, France, 2016-2017. Emerg Infect Dis. 2019;25:1204-1208. https://doi.org/10.3201/eid2506.181460. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537711/</Citation></Reference><Reference><Citation>Luciani L, Morand A, Zandotti C, et al. Circulation of enterovirus A71 during 2019-2020, Marseille, France. J Med Virol. 2021;93:5163-5166. https://doi.org/10.1002/jmv.26893. https://pubmed.ncbi.nlm.nih.gov/33605462/</Citation></Reference><Reference><Citation>Karrasch M, Fischer E, Scholten M, et al. A severe pediatric infection with a novel enterovirus A71 strain, Thuringia, Germany. J Clin Virol. 2016;84:90-95. https://doi.org/10.1016/j.jcv.2016.09.007. https://pubmed.ncbi.nlm.nih.gov/27771495/</Citation></Reference><Reference><Citation>Böttcher S, Obermeier PE, Neubauer K, Diedrich S. Recombinant enterovirus A71 subgenogroup C1 strains, Germany, 2015. Emerg Infect Dis. 2016;22:1843-1846. https://doi.org/10.3201/eid2210.160357. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038430/</Citation></Reference><Reference><Citation>Böttcher S, Diedrich S, Keeren K. Increased detection of enterovirus A71 infections, Germany, 2019. Euro Surveill. 2019;24:1-5. https://doi.org/10.2807/1560-7917.ES.2019.24.39.1900556. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6774229/</Citation></Reference><Reference><Citation>Taravilla CN, Pérez-Sebastián I, Salido AG, et al. Enterovirus A71 infection and neurologic disease, Madrid, Spain, 2016. Emerg Infect Dis. 2019;25:25-32. https://doi.org/10.3201/eid2501.181089. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302576/</Citation></Reference><Reference><Citation>Cabrerizo M, Tarrago D, Munoz-Almagro C, et al. Molecular epidemiology of enterovirus 71, coxsackievirus A16 and A6 associated with hand, foot and mouth disease in Spain. Clin Microbiol Infect. 2014;20:150-156. https://doi.org/10.1111/1469-0691.12361. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(14)60847-8/fulltext</Citation></Reference><Reference><Citation>Casas-Alba D, de Sevilla MF, Valero-Rello A, et al. Outbreak of brainstem encephalitis associated with enterovirus-A71 in Catalonia, Spain (2016): a clinical observational study in a children's reference centre in Catalonia. Clin Microbiol Infect. 2017;23:874-881. https://doi.org/10.1016/j.cmi.2017.03.016. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(17)30185-4/fulltext</Citation></Reference><Reference><Citation>González-Sanz R, Casas-Alba D, Launes C, et al. Molecular epidemiology of an enterovirus A71 outbreak associated with severe neurological disease, Spain, 2016. Euro Surveill. 2019;24:1-9. https://doi.org/10.2807/1560-7917.ES.2019.24.7.1800089. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381658/</Citation></Reference><Reference><Citation>Wieczorek M, Purzyńska M, Krzysztoszek A, Ciąćka A, Figas A, Szenborn L. Genetic characterization of enterovirus A71 isolates from severe neurological cases in Poland. J Med Virol. 2018;90:372-376. https://doi.org/10.1002/jmv.24958. https://pubmed.ncbi.nlm.nih.gov/28960454/</Citation></Reference><Reference><Citation>Akhmadishina LV, Govorukhina MV, Kovalev EV, Nenadskaya SA, Ivanova OE, Lukashev AN. Enterovirus A71 meningoencephalitis outbreak, Rostov-on-Don, Russia, 2013. Emerg Infect Dis. 2015;21:1440-1443. https://doi.org/10.3201/eid2108.141084. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517719/</Citation></Reference><Reference><Citation>Madeddu S, Giuseppina S. Enterovirus 71 in Europe: a briefing. Dev Clin. Med Pathol. 2018;1:1-3. https://crimsonpublishers.com/dcmp/fulltext/DCMP.000503.php</Citation></Reference><Reference><Citation>Puenpa J, Wanlapakorn N, Vongpunsawad S, Poovorawan Y. The history of enterovirus A71 outbreaks and molecular epidemiology in the Asia-Pacific region. J Biomed Sci. 2019;26:1-11. https://doi.org/10.1186/s12929-019-0573-2</Citation></Reference><Reference><Citation>Chan LG, Parashar UD, Lye MS, Outbreak Study Group, et al. Deaths of children during an outbreak of hand, foot, and mouth disease in Sarawak, Malaysia: clinical and pathological characteristics of the disease. Clin Infect Dis. 2000;31:678-683. https://doi.org/10.1086/314032. https://academic.oup.com/cid/article/31/3/678/296297</Citation></Reference><Reference><Citation>Ooi MH, Wong SC, Podin Y, et al. Human enterovirus 71 disease in Sarawak, Malaysia: a prospective clinical, virological, and molecular epidemiological study. Clin Infect Dis. 2007;44:646-656. https://doi.org/10.1086/511073. https://academic.oup.com/cid/article/44/5/646/347716</Citation></Reference><Reference><Citation>Ho H, Chen E-R, Hsu K-H, et al. An epidemic of enterovirus 71 infection in Taiwan. N Engl J Med. 1999;341:929-935. https://doi.org/10.1056/NEJM199909233411301. https://pubmed.ncbi.nlm.nih.gov/10498487/</Citation></Reference><Reference><Citation>Lin T-Y, Twu S-J, Ho M-S, Chang L-Y, Lee C-Y. Enterovirus 71 outbreaks, Taiwan: occurrence and recognition. Emerg Infect Dis. 2003;9:291-293. https://doi.org/10.3201/eid0903.020285. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963902/</Citation></Reference><Reference><Citation>Wang J-J, Tuan Y-C, Tsai H-P, Yan J-J, Liu C-C, Su I-J. Change of major genotype of enterovirus 71 in outbreaks of hand-foot-and-mouth disease in Taiwan between 1998 and 2000. J Clin Microbiol. 2002;40:10-15. https://doi.org/10.1128/JCM.40.1.10-15.2002. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC120096/</Citation></Reference><Reference><Citation>Kung S-H, Wang S-F, Huang C-W, Hsu C-C, Liu H-F, Yang J-Y. Genetic and antigenic analyses of enterovirus 71 isolates in Taiwan during 1998-2005. Clin Microbiol Infect. 2007;13:782-787. https://doi.org/10.1111/j.1469-0691.2007.01745.x. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(14)63416-9/fulltext</Citation></Reference><Reference><Citation>Chia M-Y, Chiang P-S, Chung W-Y, Luo S-T, Lee M-S. Epidemiology of Enterovirus 71 infections in Taiwan. Pediatr Neonatol. 2014;55:243-249. https://doi.org/10.1016/j.pedneo.2013.07.007. https://www.pediatr-neonatol.com/article/S1875-9572(13)00139-3/fulltext</Citation></Reference><Reference><Citation>Sun L-M, Zheng H-Y, Zheng H-Z, et al. An enterovirus 71 epidemic in Guangdong Province of China, 2008: epidemiological, clinical, and virogenic manifestations. Jpn J Infect Dis. 2011;64:13-18. https://doi.org/10.7883/yoken.64.13. https://pubmed.ncbi.nlm.nih.gov/21266750/</Citation></Reference><Reference><Citation>Liu JF, Xiang XM, Pu ZS, et al. Epidemic pattern of hand-foot-and-mouth disease in Xi’an, China from 2008 through 2015. BMC Infect Dis. 2019;19:1-8. https://doi.org/10.1186/s12879-018-3624-5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322279/</Citation></Reference><Reference><Citation>Fu X, Wan Z, Li Y, Hu Y, Jin X, Zhang C. National epidemiology and evolutionary history of four hand, foot and mouth disease-related enteroviruses in China from 2008 to 2016. Virol Sin. 2020;35:21-33. https://doi.org/10.1007/s12250-019-00169-2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035399/</Citation></Reference><Reference><Citation>Donato C, Hoi LT, Hoa NT, et al. Genetic characterization of enterovirus 71 strains circulating in Vietnam in 2012. Virology. 2016;495:1-9. https://doi.org/10.1016/j.virol.2016.04.026. https://www.sciencedirect.com/science/article/pii/S0042682216300939?via%3Dihub</Citation></Reference><Reference><Citation>Nhan LNT, Hong NTT, Nhu LNT, et al. Severe enterovirus A71 associated hand, foot and mouth disease, Vietnam, 2018: preliminary report of an impending outbreak. Euro Surveill. 2018;23:1-5. https://doi.org/10.2807/1560-7917.ES.2018.23.46.1800590. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247458/</Citation></Reference><Reference><Citation>Jee YM, Cheon D-S, Kim K, et al. Genetic analysis of the VP1 region of Human enterovirus 71 strains isolated in Korea during 2000. Arch Virol. 2003;148:1735-1746. https://doi.org/10.1007/s00705-003-0133-6. https://link.springer.com/article/10.1007/s00705-003-0133-6</Citation></Reference><Reference><Citation>Ryu W-S, Kang B, Hong J, et al. Enterovirus 71 infection with central nervous system involvement, South Korea. Emerg Infect Dis. 2010;16:1764-1766. https://doi.org/10.3201/eid1611.100104. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3294506/</Citation></Reference><Reference><Citation>Ishimaru Y, Nakano S, Yamaoka K, Takami S. Outbreaks of hand, foot, and mouth disease by enterovirus 71. High incidence of complication disorders of central nervous system. Arch Dis Child. 1980;55:583-588. https://doi.org/10.1136/adc.55.8.583. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1627055/</Citation></Reference><Reference><Citation>Mizuta K, Abiko C, Murata T, et al. Frequent importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003. J Clin Microbiol. 2005;43:6171-6175. https://doi.org/10.1128/JCM.43.12.6171-6175.2005. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1317214/</Citation></Reference><Reference><Citation>Ooi E-E, Phoon M-C, Ishak B, Chan S-H. Seroepidemiology of human enterovirus 71, Singapore. Emerg Infect Dis. 2002;8:995-997. https://doi.org/10.3201/eid0809.010397. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732542/</Citation></Reference><Reference><Citation>Wu Y, Yeo A, Phoon MC, et al. The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains. Int J Infect Dis. 2010;14:1076-1081. https://doi.org/10.1016/j.ijid.2010.07.006. https://www.ijidonline.com/article/S1201-9712(10)02473-2/fulltext</Citation></Reference><Reference><Citation>McMinn P, Lindsay K, Perera D, Chan HM, Chan KP, Cardosa MJ. Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J Virol. 2001;75:7732-7738. https://doi.org/10.1128/JVI.75.16.7732-7738.2001. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC115010/</Citation></Reference><Reference><Citation>Horwood PF, Andronico A, Tarantola A, et al. Seroepidemiology of human enterovirus 71 infection among children, Cambodia. Emerg Infect Dis. 2016;22:92-95. https://doi.org/10.3201/eid2201.151323. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696711/</Citation></Reference><Reference><Citation>Duong V, Mey C, Eloit M, et al. Molecular epidemiology of human enterovirus 71 at the origin of an epidemic of fatal hand, foot and mouth disease cases in Cambodia. Emerg Microbes Infect. 2016;5:1-9. https://doi.org/10.1038/emi.2016.101. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113052/</Citation></Reference><Reference><Citation>Crabol Y, Pean P, Mey C, et al. A prospective, comparative study of severe neurological and uncomplicated hand, foot and mouth forms of paediatric enterovirus 71 infections. Int J Infect Dis. 2017;59:69-76. https://doi.org/10.1016/j.ijid.2017.04.005</Citation></Reference><Reference><Citation>Linsuwanon P, Puenpa J, Huang S-W, et al. Epidemiology and seroepidemiology of human enterovirus 71 among Thai populations. J Biomed Sci. 2014;21:1-13. https://doi.org/10.1186/1423-0127-21-16. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937078/</Citation></Reference><Reference><Citation>Puenpa J, Auphimai C, Korkong S, Vongpunsawad S, Poovorawan Y. Enterovirus A71 infection, Thailand, 2017. Emerg Infect Dis. 2018;24:1386-1387. https://doi.org/10.3201/eid2407.171923. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038748/</Citation></Reference><Reference><Citation>Noisumdaeng P, Korkusol A, Prasertsopon J, et al. Longitudinal study on enterovirus A71 and coxsackievirus A16 genotype/subgenotype replacements in hand, foot and mouth disease patients in Thailand, 2000-2017. Int J Infect Dis. 2019;80:84-91. https://doi.org/10.1016/j.ijid.2018.12.020. https://www.ijidonline.com/article/S1201-9712(19)30014-1/fulltext</Citation></Reference><Reference><Citation>Putri ND, Wiyatno A, Kinobe R, et al. Genetic characterization of enterovirus 71 from a sibling of a fatal case of hand, foot and mouth disease in Jakarta, Indonesia. Southeast Asian J Trop Med Public Health. 2021;52:828-835. https://journal.seameotropmednetwork.org/index.php/jtropmed/article/view/499</Citation></Reference><Reference><Citation>Wiyatno A, Antonjaya U, Ma'roef CN, et al. Detection and identification of coxsackievirus B3 from sera of an Indonesian patient with undifferentiated febrile illness. J Infect Dev Ctries. 2016;10:880-883. https://doi.org/10.3855/jidc.7573. https://jidc.org/index.php/journal/article/view/27580335/1565</Citation></Reference><Reference><Citation>Wiyatno A, Febrianti ESZ, Dewantari AK, Myint KS, Safari D, Idris NS. Characterization of rhinovirus C from a 4-year-old boy with acute onset dilated cardiomyopathy in Jakarta, Indonesia. JMM Case Rep. 2018;5:1-4. https://doi.org/10.1099/jmmcr.0.005139. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230756/</Citation></Reference><Reference><Citation>Gilbert GL, Dickson KE, Waters MJ, Kennett ML, Land SA, Sneddon M. Outbreak of enterovirus 71 infection in Victoria, Australia, with a high incidence of neurologic involvement. Pediatr Infect Dis J. 1988;7:484-488. https://doi.org/10.1097/00006454-198807000-00007. https://pubmed.ncbi.nlm.nih.gov/2841639/</Citation></Reference><Reference><Citation>McMinn P, Stratov I, Nagarajan L, Davis S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis. 2001;32:236-242. https://doi.org/10.1086/318454. https://academic.oup.com/cid/article/32/2/236/319948</Citation></Reference><Reference><Citation>Horsley E, Just E, Torres C, Huhtinen E, Forssman B, Slade R. Enterovirus 71 outbreak in Northern Sydney, 2013: case series and initial response. J Paediatr Child Health. 2014;50:525-530. https://doi.org/10.1111/jpc.12625</Citation></Reference><Reference><Citation>Zander A, Britton PN, Navin T, Horsley E, Tobin S, McAnulty JM. An outbreak of enterovirus 71 in metropolitan Sydney: enhanced surveillance and lessons learnt. Med J Aust. 2014;201:663-666. https://doi.org/10.5694/mja14.00014. https://pubmed.ncbi.nlm.nih.gov/25495312/</Citation></Reference><Reference><Citation>Chakraborty R, Iturriza-Gómara M, Musoke R, Palakudy T, D’Agostino A, Gray J. An epidemic of enterovirus 71 infection among HIV-1-infected orphans in Nairobi. AIDS. 2004;18:1968-1970. https://doi.org/10.1097/00002030-200409240-00018</Citation></Reference><Reference><Citation>Bessaud M, Pillet S, Ibrahim W, et al. Molecular characterization of human enteroviruses in the Central African Republic: uncovering wide diversity and identification of a new human enterovirus A71 genogroup. J Clin Microbiol. 2012;50:1650-1658. https://doi.org/10.1128/JCM.06657-11. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3347117/</Citation></Reference><Reference><Citation>Sadeuh-Mba SA, Bessaud M, Massenet D, et al. High frequency and diversity of species C enteroviruses in Cameroon and neighboring countries. J Clin Microbiol. 2013;51:759-770. https://doi.org/10.1128/JCM.02119-12. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3592076/</Citation></Reference><Reference><Citation>Faleye TOC, Adewumi MO, Coker BA, Nudamajo FY, Adeniji JA. Direct detection and identification of enteroviruses from faeces of healthy Nigerian children using a cell-culture independent RT-seminested PCR assay. Adv Virol. 2016:1-12. https://doi.org/10.1155/2016/1412838. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818813/</Citation></Reference><Reference><Citation>Fernandez-Garcia MD, Kebe O, Fall AD, et al. Enterovirus A71 genogroups C and E in children with acute flaccid paralysis, West Africa. Emerg Infect. 2016;22:753-755. https://doi.org/10.3201/eid2204.151588. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806963/</Citation></Reference><Reference><Citation>Artika IM, Wiyatno A, Ma'roef CN. Pathogenic viruses: molecular detection and characterization. Infect Genet Evol. 2020;81:1-14. https://doi.org/10.1016/j.meegid.2020.104215. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106233/</Citation></Reference><Reference><Citation>Singh S, Chow VTK, Phoon MC, Chan KP, Poh CL. Direct detection of enterovirus 71 (EV-A71) in clinical specimens from a hand, foot, and mouth disease outbreak in Singapore by reverse transcription-PCR with universal enterovirus and EV-A71-specific primers. J Clin Microbiol. 2002;40:2823-2827. https://doi.org/10.1128/jcm.40.8.2823-2827.2002. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC120643/</Citation></Reference><Reference><Citation>Lee M-H, Huang LM, Wong W-W, Wu T-Z, Chiu T-F, Chang L-Y. Molecular diagnosis and clinical presentations of enteroviral infections in Taipei during the 2008 epidemic. J Microbiol Immunol Infect. 2011;44:178-183. https://doi.org/10.1016/j.jmii.2011.01.018. https://pubmed.ncbi.nlm.nih.gov/21524611/</Citation></Reference><Reference><Citation>Chiang P-S, Huang M-L, Luo S-T, Lin T-Y, Tsao K-C, Lee MS. Comparing molecular methods for early detection and serotyping of enteroviruses in throat swabs of pediatric patients. PLoS One. 2012;7:1-6. https://doi.org/10.1371/journal.pone.0048269. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484998/</Citation></Reference><Reference><Citation>Khanh TH, Sabanathan S, Thanh TT, et al. Enterovirus 71-associated hand, foot, and mouth disease, Southern Vietnam, 2011. Emerg Infect Dis. 2012;18:2002-2005. https://doi.org/10.3201/eid1812.120929. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557876/</Citation></Reference><Reference><Citation>Nix WA, Oberste MS, Pallansch MA. Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J Clin Microbiol. 2006;44:2698-2704. https://doi.org/10.1128/JCM.00542-06. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1594621/</Citation></Reference><Reference><Citation>Fujimoto T, Yoshida S, Munemura M, et al. Detection and quantification of enterovirus 71 genome from cerebrospinal fluid of an encephalitis patient by PCR applications. Jpn J Infect Dis. 2008;61:497-499. https://pubmed.ncbi.nlm.nih.gov/19050366/</Citation></Reference><Reference><Citation>WHO. Enterovirus Surveillance Guidelines. Guidelines for Enterovirus Surveillance in Support of the Polio Eradication Initiative; 2015. Accessed April 6, 2022. https://www.euro.who.int/__data/assets/pdf_file/0020/272810/EnterovirusSurveillanceGuidelines.pdf</Citation></Reference><Reference><Citation>Artika IM, Ma’roef CN. Laboratory biosafety for handling emerging viruses. Asian Pac J Trop Biomed. 2017;7:483-491. https://doi.org/10.1016/j.apjtb.2017.01.020. https://www.sciencedirect.com/science/article/pii/S2221169116306414</Citation></Reference><Reference><Citation>Artika IM, Ma’roef CN. Current laboratory biosecurity for handling pathogenic viruses. Am J Biochem Biotechnol. 2018;14:108-116. https://doi.org/10.3844/ajbbsp.2018.108.116. https://thescipub.com/abstract/10.3844/ajbbsp.2018.108.116</Citation></Reference><Reference><Citation>Volle R, Joffret M-L, Ndiaye K, et al. Development of a new internally controlled one-step real-time RT-PCR for the molecular detection of enterovirus A71 in Africa and Madagascar. Front Microbiol. 2020;11:1-15. https://doi.org/10.3389/fmicb.2020.01907. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456875/</Citation></Reference><Reference><Citation>Zhang F, Hao C, Zhang S, et al. Oral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge. Virol J. 2014;11:1-9. https://doi.org/10.1186/1743-422X-11-80. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022980/</Citation></Reference><Reference><Citation>Niu P, Qi S, Yu B, et al. Development of a highly sensitive real-time nested RT-PCR assay in a single closed tube for detection of enterovirus 71 in hand, foot, and mouth disease. Arch Virol. 2016;161:3003-3010. https://doi.org/10.1007/s00705-016-2985-6. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086773/</Citation></Reference><Reference><Citation>Wang Y, Li Y, Yang Y, et al. Virological investigation of genetic variation of enterovirus type 71 in hand, foot and mouth disease. Exp Ther Med. 2020;20:543-549. https://doi.org/10.3892/etm.2020.8728. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281934/</Citation></Reference><Reference><Citation>Huang K, Zhang Y, Han Z, et al. Global Spread of the B5 Subgenotype EV-A71 and the phylogeographical analysis of Chinese migration events. Front Cell Infect Microbiol. 2020;10:1-11. https://doi.org/10.3389/fcimb.2020.00475. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546772/</Citation></Reference><Reference><Citation>Wen H-L, Si L-Y, Yuan X-J, et al. Complete genome sequencing and analysis of six enterovirus 71 strains with different clinical phenotypes. Virol J. 2013;10:1-11. https://doi.org/10.1186/1743-422X-10-115. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669102/</Citation></Reference><Reference><Citation>Lin J-Y, Kung Y-A, Shih S-R. Antivirals and vaccines for Enterovirus A71. J Biomed Sci. 2019;26:1-10. https://doi.org/10.1186/s12929-019-0560-7. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720414/</Citation></Reference><Reference><Citation>Zhang D, Lu J, Lu J. Enterovirus 71 vaccine: close but still far. Int J Infect Dis. 2010;14:739-743. https://doi.org/10.1016/j.ijid.2009.12.002. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110504/</Citation></Reference><Reference><Citation>Li M-L, Shih S-R, Tolbert BS, Brewer G. Enterovirus A71 vaccines. Vaccines. 2021;9:1-10. https://doi.org/10.3390/vaccines9030199. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997495/</Citation></Reference><Reference><Citation>Yi E-J, Shin Y-J, Kim J-H, Kim T-G, Chang S-Y. Enterovirus 71 infection and vaccines. Clin Exp Vaccine Res. 2017;6:4-14. https://doi.org/10.7774/cevr.2017.6.1.4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292356/</Citation></Reference><Reference><Citation>Lim HX, Poh CL. Insights into innate and adaptive immune responses in vaccine development against EV-A71. Ther Adv Vaccines Immunother. 2019;7:1-10. https://doi.org/10.1177/2515135519888998. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873268/</Citation></Reference><Reference><Citation>Yee PTI, Tan SH, Ong KC, et al. Development of live attenuated enterovirus 71 vaccine strains that confer protection against lethal challenge in mice. Sci Rep. 2019;18:1-15. https://doi.org/10.1038/s41598-019-41285-z. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423319/</Citation></Reference><Reference><Citation>Wu CN, Lin YC, Fann C, Liao NS, Shih SR, Ho MS. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine. 2001;20:895-904. https://doi.org/10.1016/s0264-410x(01)00385-1. https://pubmed.ncbi.nlm.nih.gov/11738755/</Citation></Reference><Reference><Citation>Roldão A, Mellado MCM, Castilho LR, Carrondo MJT, Alves PM. Virus-like particles in vaccine development. Expert Rev Vaccines. 2010;9:1149-1176. https://doi.org/10.1586/erv.10.115. https://www.tandfonline.com/doi/abs/10.1586/erv.10.115?journalCode=ierv20</Citation></Reference><Reference><Citation>Wang X, Ku Z, Zhang X, et al. Structure, immunogenicity, and protective mechanism of an engineered enterovirus 71-like particle vaccine mimicking 80S empty capsid. J Virol. 2018;92:1-18. https://doi.org/10.1128/JVI.01330-17. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730765/</Citation></Reference><Reference><Citation>Tung WS, AbuBakar S, Sekawi Z, Rosli R. DNA vaccine constructs against enterovirus 71 elicit immune response in mice. Genet Vaccines Ther. 2007;5:1-13. https://doi.org/10.1186/1479-0556-5-6. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3225814/</Citation></Reference><Reference><Citation>Flingai S, Czerwonko M, Goodman J, Kudchodkar SB, Muthumani K, Weiner DB. Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants. Front Immunol. 2013;4:1-10. https://doi.org/10.3389/fimmu.2013.00354. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816528/</Citation></Reference><Reference><Citation>Khan KH. DNA vaccines: roles against diseases. Germs. 2013;3:26-35. https://doi.org/10.11599/germs.2013.1034. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882840/</Citation></Reference><Reference><Citation>Li W, Joshi MD, Singhania S, Ramsey KH, Murthy AK. Peptide vaccine: progress and challenges. Vaccines (Basel). 2014;2:515-536. https://doi.org/10.3390/vaccines2030515. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494216/</Citation></Reference><Reference><Citation>Kim Y-G, Lee Y, Kim JH, et al. Self-assembled multi-epitope peptide amphiphiles enhance the immune response against enterovirus 71. Nanomaterials (Basel). 2020;10:1-12. https://doi.org/10.3390/nano10122342. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760352/</Citation></Reference><Reference><Citation>Lin Y-L, Chow Y-H, Huang L-M, et al. A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge. Sci Rep. 2018;8:1-11. https://doi.org/10.1038/s41598-018-28281-5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048030/</Citation></Reference><Reference><Citation>Tan CW, Lai JKF, Sam I-C, Chan YF. Recent developments in antiviral agents against enterovirus 71 infection. J Biomed Sci. 2014;21:1-11. https://doi.org/10.1186/1423-0127-21-14. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924904/</Citation></Reference><Reference><Citation>Lin Z, Li Y, Xu T, et al. Inhibition of enterovirus 71 by selenium nanoparticles loaded with siRNA through Bax signaling pathways. ACS Omega. 2020;5:12495-12500. https://doi.org/10.1021/acsomega.0c01382. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271353/</Citation></Reference><Reference><Citation>Falah N, Montserret R, Lelogeais V, et al. Blocking human enterovirus 71 replication by targeting viral 2A protease. J Antimicrob Chemother. 2012;67:2865-2869. https://doi.org/10.1093/jac/dks304. https://academic.oup.com/jac/article/67/12/2865/775113</Citation></Reference><Reference><Citation>Lin Y-J, Chang YC, Hsiao N-W, et al. Fisetin and rutin as 3C protease inhibitors of enterovirus A71. J Virol Methods. 2012;182:93-98. https://doi.org/10.1016/j.jviromet.2012.03.020. https://pubmed.ncbi.nlm.nih.gov/22465253/</Citation></Reference><Reference><Citation>Cao Z, Ding Y, Ke Z, et al. Luteoloside acts as 3C protease inhibitor of enterovirus 71 in vitro. PLoS One. 2016;11:1-13. https://doi.org/10.1371/journal.pone.0148693. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752227/</Citation></Reference><Reference><Citation>Lalani S, Poh CL. Flavonoids as antiviral agents for enterovirus A71 (EV-A71). Viruses. 2020;12:1-34. https://doi.org/10.3390/v12020184. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077323/</Citation></Reference><Reference><Citation>Huang X, Zhang X, Wang F, et al. Clinical efficacy of therapy with recombinant human interferon α1b in hand, foot, and mouth disease with enterovirus 71 infection. PLoS One. 2016;11:1-9. https://doi.org/10.1371/journal.pone.0148907. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755579/</Citation></Reference><Reference><Citation>Hung H-C, Wang H-C, Shih S-R, Teng I-F, Tseng C-P, Hsu JT-A. Synergistic inhibition of enterovirus 71 replication by interferon and rupintrivir. J Infect Dis. 2011;203:1784-1790. https://doi.org/10.1093/infdis/jir174. https://academic.oup.com/jid/article/203/12/1784/927651</Citation></Reference><Reference><Citation>Artika IM, Budirahardja Y, Ekowati AL. Molecular cloning and heterologous expression of human interferon alpha2b gene. Am J Biochem Biotechnol. 2013;9:423-429. https://doi.org/10.3844/ajbbsp.2013.423.429. https://thescipub.com/pdf/ajbbsp.2013.423.429.pdf</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>